Search…

BridgeBio (BBIO.US) accuses Pfizer (PFE.US) and Alnylam (ALNY.US) of using "controversial tactics" to compete in the multi-billion-dollar cardiovascular drug market.

12/09/2025

According to the China Fortune Financial APP, BridgeBio Pharma (BBIO.US) is competing with Pfizer (PFE.US) and Alnylam Pharmaceuticals (ALNY.US) with a heart disease drug. The company claims that its drug is more effective and lower in cost, but also accuses competitors of using "controversial strategies" in this billion-dollar market.

Latest

1 m ago

Inspur's trading volume has reached 10 billion yuan, currently up by 6.91%.

1 m ago

Hong Kong stocks real estate stocks rise, Far Ocean Group soars by more than 15%, leading Rongxin China's rise by more than 7%, China Jinmao rises by 5.2%, Country Garden rises by nearly 5%, Longfor Group, Agile Group, Sun Hung Kai Properties Group all rise by nearly 4%, Frasers Property, Kaisa Group, Yuexiu Property, Vanke Enterprises all have an increase of over 2.5%.

1 m ago

Hong Kong stocks' property stocks are rising, with China Overseas Land & Investment leading with a surge of over 15%. Rongxin China rose more than 7%, China Jinmao rose 5.2%, Country Garden rose nearly 5%, Longfor Group, Joy City Property, Sunshine City Group rose nearly 4%, Forte Properties, Xin Cheng Development, Yuexiu Properties, and Vanke Enterprises all rose by more than 2.5%.

2 m ago

Hong Kong stock market anomaly | Cloud computing concept stocks continue to rise, Oracle's huge computing power order shakes the market, North American cloud companies increase capital expenditure budgets.

3 m ago

Liu Pharmaceutical Group and Huawei hold a high-level exchange discussion to explore cooperation in pharmaceutical intelligence.

See all latest